EP2500030

Use of complement pathway inhibitors to treat ocular diseases

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    4.11.2006
  • EP published:
    22.7.2015
  • EP application number:
    12172001.5
  • Max expiry date:
    3.11.2026
  • Title:
    Use of complement pathway inhibitors to treat ocular diseases

Timeline

Today
4.11.2006EP application
22.7.2015EP Publication

Owner

  • Name:
    Genentech, Inc.
  • Address:
    1 DNA Way, 94080-4990, South San Francisco CA, US

Inventor

  • Name:
    Fung, Sek Chung
  • Address:
    Gaithersburg, MD, US
  • Name:
    Yao, Zhengbin
  • Address:
    Berwyn, PA, US

Priority

  • Number:
    733763 P
  • Date:
    4.11.2005
  • Country:
    US

Classification

  • Categories:
    A61K 38/00, C07K 17/00, A61K 39/395, C07K 16/18, A61K 48/00, A61K 39/00

Upload documents